| 2007 |
Targeted disruption of AdipoR1 in mice abrogates adiponectin-induced AMPK activation, demonstrating that AdipoR1 is required for adiponectin-mediated AMPK signaling in vivo. Simultaneous disruption of both AdipoR1 and AdipoR2 abolished adiponectin binding entirely. |
Targeted gene disruption (knockout mice), adenovirus-mediated receptor expression in liver, AMPK activation assays |
Nature medicine |
High |
17268472
|
| 2010 |
AdipoR1 mediates adiponectin-induced extracellular Ca2+ influx in myocytes, which is required for subsequent activation of CaMKKβ, AMPK, and SIRT1, leading to increased PGC-1α expression and deacetylation, and increased mitochondrial content. Muscle-specific disruption of AdipoR1 suppressed adiponectin-mediated intracellular Ca2+ increases and downstream CaMKK/AMPK/SIRT1 activation. |
Muscle-specific AdipoR1 knockout mice, intracellular Ca2+ measurements, CaMKK/AMPK/SIRT1 activity assays, mitochondrial content measurements |
Nature |
High |
20357764
|
| 2007 |
AdipoR1 mediates adiponectin-induced IL-6 production in synovial fibroblasts via an AdipoR1/AMPK/p38/IKKαβ/NF-κB signaling pathway; AdipoR1 siRNA knockdown attenuated adiponectin-mediated AMPK activation, IKK activity, NF-κB nuclear translocation, and IL-6 production. |
siRNA knockdown of AdipoR1, AMPK kinase activity assays, NF-κB luciferase reporter, IKK activity assays, Western blot for p38 and AMPK phosphorylation |
Journal of immunology |
Medium |
17911635
|
| 2008 |
AdipoR1, but not AdipoR2, mediates adiponectin's anorexigenic effects in the hypothalamus; AdipoR1 is required for adiponectin-induced activation of IRS1/2, ERK, Akt, FOXO1, JAK2, and STAT3 signaling in the arcuate and lateral hypothalamic nuclei, and for reduction of food intake following icv adiponectin. |
Intracerebroventricular (icv) adiponectin injection, receptor inhibition, signaling pathway activation assays (Western blot), food intake measurements |
FEBS letters |
Medium |
18394428
|
| 2009 |
Adiponectin suppresses hepatic SREBP1c expression through AdipoR1 and its upstream kinase LKB1/AMPK pathway; deletion of LKB1 cancelled the negative effect of adiponectin on SREBP1c, placing AdipoR1 upstream of LKB1 in this pathway. |
AdipoR1 knockdown, LKB1 deletion in hepatocytes, SREBP1c expression assays in db/db mice and cultured hepatocytes |
Biochemical and biophysical research communications |
Medium |
19254698
|
| 2008 |
AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway in vascular smooth muscle, endothelial cells, and hepatocytes. Downregulation of APPL1 impaired adiponectin-stimulated ERK1/2 activation. Inhibition of Src family tyrosine kinases abolished the response; Clostridium difficile toxin B (Rho/Rac inhibitor) also abolished it. Adiponectin caused Src-dependent Ras activation. |
RNA interference (siRNA) for AdipoR1/R2 and APPL1, pharmacological inhibitors (PP2 for Src, C. difficile toxin B), Ras and ERK1/2 activation assays, HEK293 cell growth assays |
Biochemistry |
Medium |
18842004
|
| 2010 |
ERp46 interacts specifically with AdipoR1 (but not AdipoR2) via the cytoplasmic N-terminal residues (1–70) of AdipoR1. ERp46 is present in both the ER and plasma membrane. Knockdown of ERp46 increased AdipoR1 (and AdipoR2) at the plasma membrane, correlated with increased adiponectin-stimulated AMPK phosphorylation, but reduced adiponectin-stimulated p38MAPK phosphorylation. |
Co-immunoprecipitation followed by mass spectrometry, GST-fusion protein pulldowns with truncation constructs, indirect immunofluorescence, subcellular fractionation, siRNA knockdown, AMPK and p38MAPK phosphorylation assays |
Biochemical and biophysical research communications |
High |
20074551
|
| 2011 |
AdipoR1 mediates adiponectin-induced MMP-3 expression in human chondrocytes via AdipoR1/AMPK/p38/NF-κB pathway; AdipoR1 (but not AdipoR2) siRNA knockdown attenuated this response. |
siRNA knockdown of AdipoR1 vs AdipoR2, qPCR, Western blot, ELISA for MMP-3, kinase inhibitor assays (AMPK inhibitor, p38 inhibitor, NF-κB inhibitor) |
Journal of cellular biochemistry |
Medium |
21321996
|
| 2011 |
Globular adiponectin protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via AdipoR1/APPL1 signaling; AdipoR1 siRNA knockdown attenuated adiponectin's anti-oxidative and anti-apoptotic effects (ROS reduction and caspase-3 activity), and APPL1 knockdown similarly abrogated these protective effects. |
siRNA knockdown of AdipoR1 and APPL1, TUNEL/annexin V apoptosis assays, cytochrome c release, caspase-3 activation, ROS measurement |
PloS one |
Medium |
21552570
|
| 2011 |
AdipoR1 is required for adiponectin-induced suppression of NF-κB in lung epithelial A549 cells; AdipoR1 siRNA silencing abrogated NF-κB nuclear trans-activation by adiponectin, whereas AdipoR2 knockdown did not affect this response. |
siRNA knockdown of AdipoR1 vs AdipoR2, NF-κB nuclear trans-activation assay, ERK1/2 and AKT signaling, cell viability assay |
The international journal of biochemistry & cell biology |
Medium |
23500159
|
| 2011 |
AdipoR1 is required by adiponectin to suppress TNFα and MCP-1 gene expression in macrophage foam cells; APPL1 knockdown abrogated adiponectin-mediated inhibition of lipid accumulation, SR-AI, NF-κB gene expression, and Akt phosphorylation. AdipoR1 and AdipoR2 have differential roles: AdipoR2 dominantly mediates suppression of SR-AI and upregulation of IL-1Ra. |
Overexpression and knockdown of AdipoR1/AdipoR2, lentiviral shRNA knockdown of APPL1, foam cell formation assay with oxLDL, cytokine gene expression, Akt phosphorylation |
Atherosclerosis |
Medium |
22227293
|
| 2009 |
Adiponectin inhibits LPS-induced adventitial fibroblast migration and transformation to myofibroblasts via AdipoR1/AMPK/iNOS pathway; AdipoR1 siRNA reversed adiponectin's inhibition of AMPK phosphorylation and iNOS/NO/ONOO- production induced by LPS. |
siRNA knockdown of AdipoR1 and AMPK, siAMPK, AMPK inhibitor, migration/scratch-wound assays, iNOS RT-PCR and Western blot, NO and ONOO- assays, in vivo adenovirus-adiponectin in ApoE-KO mice |
Molecular endocrinology |
Medium |
19889816
|
| 2008 |
In renal distal tubules, adiponectin acts through luminal AdipoR1 (not AdipoR2, which was undetected) to activate AMPK, leading to inhibition of glycogen synthase (GS). In diabetic rats, this AdipoR1/AMPK regulation is impaired, correlating with glycogen accumulation. |
Western blot of isolated distal tubules, immunohistochemistry, in vitro AICAR and globular adiponectin treatment of isolated tubules from normal and STZ-diabetic rats, GS activity assays |
American journal of physiology. Renal physiology |
Medium |
18256313
|
| 2015 |
AdipoR1 mediates ischemic postconditioning (IPo) cardioprotection through an APN/AdipoR1/Caveolin-3 pathway that activates mitochondrial STAT3 (mitoSTAT3). Specific AdipoR1 gene knockdown or caveolin-3 disruption abolished adiponectin's ability to activate STAT3 and confer cardioprotection. In diabetes, impaired AdipoR1/Cav3 signaling underlies loss of IPo cardioprotection. |
AdipoR1 siRNA knockdown, caveolin-3 disruption, APN knockout mice, STAT3 activation assays, myocardial I/R injury model, mitochondrial STAT3 fractionation |
Diabetes |
Medium |
26718505
|
| 2016 |
A heterozygous missense mutation in ADIPOR1 (p.Y310C) causes autosomal dominant retinitis pigmentosa; the mutation affects protein folding and subcellular localization in vitro. Knockdown of adipor1 in zebrafish preferentially reduces rod photoreceptors, and the phenotype is rescued by wild-type but not mutant human ADIPOR1 mRNA. |
Exome sequencing, in vitro expression with localization studies (protein folding/localization), zebrafish morpholino knockdown, mRNA rescue experiment |
Human genetics |
Medium |
27655171
|
| 2016 |
ADIPOR1 is identified as a novel disease-causing gene for syndromic retinitis pigmentosa; a homozygous frameshift mutation (c.31delC, p.Q11Rfs*24) was found in a patient with retinal dystrophy, obesity, and behavioral abnormalities — a phenotype mirrored by Adipor1-null mice. ADIPOR1 expression was confirmed in retina by immunohistochemistry. |
Whole-exome sequencing, variant filtering, immunohistochemistry of retina |
Human mutation |
Medium |
26662040
|
| 2018 |
Post-developmental knockout of AdipoR1 in photoreceptors or in the retinal pigment epithelium (RPE) results in decreased expression of retinal proteins and depletes RHODOPSIN prior to photoreceptor death, establishing a role for ADIPOR1 in supporting vision in adulthood. Loss of ADIPOR1 in the RPE layer alone (as in Mfrprd6 mice) is sufficient to drive retinal degeneration. |
Conditional (cell-type-specific) AdipoR1 knockout mice (photoreceptor-specific and RPE-specific), electroretinography, retinal protein expression analysis, comparison with Mfrprd6 mouse model |
Scientific reports |
High |
30254279
|
| 2022 |
Absence of AdipoR1 in mice leads to ceramide accumulation in the retina due to insufficient ceramidase activity, causing photoreceptor degeneration. Single-cell RNA-seq identified ADIPOR1 as the most abundantly expressed ceramidase in mouse retina and one of the two most highly expressed in human retina. Pharmacological reduction of ceramides with desipramine/L-cycloserine rescued photoreceptors and improved visual function in AdipoR1 KO mice. |
AdipoR1 knockout mice, single-cell RNA-seq, ceramide mass spectrometry, electroretinography, visual cortex electrophysiology, pharmacological treatment (desipramine/L-cycloserine), in vitro causal relationship assay for ELOVL2 |
JCI insight |
High |
35015730
|
| 2021 |
ADIPOR1 deficiency in the retina suppresses ELOVL2 expression and reduces docosahexaenoic acid (DHA) levels, which are critical for photoreceptor outer segment formation. This causal relationship between ADIPOR1 deficiency and ELOVL2 repression was confirmed in vitro, and lipogenic gene upregulation consistent with reduced endogenous DHA synthesis was observed. |
Adipor1 knockout mice, electroretinography, electron microscopy, lipid composition analysis (mass spectrometry), ELOVL2 mRNA and protein assays, in vitro causal confirmation |
Cell death & disease |
Medium |
33963174
|
| 2019 |
AdipoR1 maintains membrane fluidity in most human cell types independently of adiponectin, by sustaining desaturase expression and high levels of unsaturated fatty acids in membrane phospholipids and preventing membrane rigidification under palmitate challenge. This was demonstrated without exogenous adiponectin, showing AdipoR1 has an adiponectin-independent lipid homeostasis function. |
AdipoR1/AdipoR2 knockdown in multiple human cell types (including primary HUVECs), FRAP (fluorescence recovery after photobleaching), Laurdan dye generalized polarization, mass spectrometry of phospholipid FA composition |
Journal of lipid research |
High |
30890562
|
| 2020 |
Crystal structure determination of the D208A variant AdipoR1 reveals a closed-open interconversion of the receptor's internal cavity: helices IV and V tilt with intracellular ends shifting ~4 and ~11 Å respectively between closed and open forms. Re-analysis of wild-type AdipoR1 diffraction data showed a 44:56 mixture of closed and open forms, suggesting this conformational change is relevant to receptor function. |
X-ray crystallography of D208A AdipoR1 variant, re-analysis of wild-type AdipoR1 diffraction data, structural comparison of asymmetric unit molecules |
Communications biology |
High |
32796916
|
| 2013 |
AdipoR1 translation is co-regulated post-transcriptionally by both miR-221 and the RNA-binding protein PTB (polypyrimidine tract-binding protein) acting on the AdipoR1 3'UTR. PTB and miR-221 cooperatively inhibit AdipoR1 protein synthesis; depletion of either increases AdipoR1 protein, and overexpression decreases it. During myogenesis, downregulation of PTB and miR-221 induces AdipoR1 translation. |
RNA immunoprecipitation, luciferase reporter assays (3'UTR), siRNA depletion and overexpression of PTB and miR-221, myogenesis differentiation model, mouse obesity models |
Diabetes |
High |
24130336
|
| 2012 |
AdipoR1 overexpression in rat skeletal muscle increases glucose uptake, glycogen accumulation, IRS-1/Akt/GSK-3β phosphorylation, AMPK/ACC phosphorylation, APPL1 protein levels, PGC-1α and UCP3 expression, and reduces specific ceramide species and ceramide synthetic enzyme mRNAs, thereby locally ameliorating insulin resistance. |
In vivo electrotransfer-mediated AdipoR1 overexpression in single muscles, hyperinsulinemic-euglycemic clamp, glucose uptake measurement, sphingolipid mass spectrometry, Western blot for multiple signaling proteins |
Endocrinology |
Medium |
22989629
|
| 2018 |
AdipoR1 is expressed in serotonin (5-HT) neurons of the dorsal raphe nucleus; selective deletion of AdipoR1 in 5-HT neurons reduces TPH2 expression and 5-HT immunoreactivity in DRN, hippocampus, and mPFC in male mice, increases SERT expression, and causes depression-related behavioral phenotypes in a sex-dependent manner. |
Conditional (5-HT neuron-specific) AdipoR1 knockout mice, immunofluorescence co-localization (AdipoR1/TPH2), behavioral tests (saccharin preference, forced swim, sucrose preference), immunohistochemistry for TPH2, SERT, 5-HT, pharmacological test with fluoxetine vs desipramine |
Molecular psychiatry |
High |
31980728
|
| 2018 |
AdipoR1 is expressed in VTA dopamine neurons; ablation of AdipoR1 specifically from dopamine neurons enhances neuronal firing and anxiogenic responses to stress. Intra-VTA adiponectin infusion decreases basal dopamine neuron firing and reverses stress-induced increases in activity, and these effects are abolished in mice lacking AdipoR1 in dopamine neurons. |
Dopamine neuron-specific AdipoR1 knockout mice, intra-VTA adiponectin/AdipoRon infusion, in vivo electrophysiology (dopamine neuron firing rate and population activity), behavioral anxiety tests, adiponectin haploinsufficiency model |
Molecular psychiatry |
High |
29988086
|
| 2018 |
Adiponectin attenuates neuronal apoptosis after neonatal hypoxia-ischemia via AdipoR1/APPL1/LKB1/AMPK signaling pathway; siRNA knockdown of AdipoR1, APPL1, or LKB1 abolished the anti-apoptotic effects of recombinant adiponectin, placing them in an epistatic pathway. |
Intracerebroventricular siRNA for AdipoR1, APPL1, LKB1 in neonatal rats, intranasal recombinant adiponectin, brain infarct measurement, TUNEL/FJC staining, Western blot for LKB1, p-AMPK, Cleaved-Caspase 3 |
Neuropharmacology |
Medium |
29486166
|
| 2019 |
AdipoR1 knockdown in BV2 microglia inhibited adiponectin's ability to suppress AβO-induced TNFα and IL-1β release and to prevent the AβO-induced decrease in AMPK phosphorylation and NF-κB nuclear translocation. AdipoR2 knockdown had no such effect, establishing AdipoR1-specific mediation of APN's anti-inflammatory effects in microglia. |
siRNA knockdown of AdipoR1 vs AdipoR2, AMPK inhibitor (compound C), ELISA for cytokines, Western blot for p-AMPK, immunofluorescence for NF-κB nuclear translocation, MTT assay for neuroprotection, APN-/-5xFAD mice |
Journal of neuroinflammation |
Medium |
31128596
|
| 2014 |
AdipoR1-deficient mice develop severe metabolic dysfunction under diet-induced obesity, whereas AdipoR2-deficient mice are protected, demonstrating divergent in vivo metabolic roles for the two receptors. In contrast, AdipoR2 (not AdipoR1) is functionally required for revascularization in hindlimb ischemia and for the revascularization actions of adiponectin. |
AdipoR1 and AdipoR2 knockout mice, chronic hindlimb ischemia surgery, blood flow recovery measurement, diet-induced obesity model, metabolic phenotyping |
The Journal of biological chemistry |
High |
24742672
|
| 2022 |
Ionizing radiation upregulates AdipoR1 expression in HCC cells, which promotes Nrf2 protein stability; Nrf2 then binds the xCT promoter to increase xCT transcription, reducing ferroptosis. AdipoR1 knockdown inhibited Nrf2 and xCT expression and increased IR-induced and erastin-induced ferroptosis; this was rescued by Nrf2 or xCT restoration. |
AdipoR1 siRNA knockdown, Nrf2 rescue, xCT rescue, xCT promoter-Nrf2 binding assay, ferroptosis assays (cell death, lipid peroxidation), erastin treatment |
Oxidative medicine and cellular longevity |
Medium |
35733794
|
| 2020 |
AdipoR1 deficiency in T cells inhibits Th17 cell differentiation in vitro and ameliorates joint inflammation in antigen-induced arthritis mice. Mechanistically, AdipoR1 knockout reduced HIF-1α expression, leading to glycolysis inhibition during naïve CD4+ T cell differentiation into Th17 cells; RNAseq showed greatest downregulation of Rorc in AdipoR1-KO T cells. |
T cell lineage-specific AdipoR1 conditional knockout, RNA-sequencing, Th17 differentiation assays in vitro, antigen-induced arthritis in vivo model, HIF-1α expression and glycolysis assays |
Frontiers in immunology |
Medium |
32973810
|
| 2017 |
Globular adiponectin exerts anti-inflammatory and anti-oxidant actions on microglia via an AdipoR1/NF-κB signaling pathway; AdipoR1 (but not AdipoR2) knockdown abolished these effects in BV2 cells and primary microglia. |
siRNA knockdown of AdipoR1 vs AdipoR2, NF-κB pathway assays, cytokine measurement (IL-1β, IL-6, TNFα), nitrosative/oxidative stress measurement in microglia, in vivo LPS challenge in APN-deficient mice |
Frontiers in cellular neuroscience |
Medium |
29184485
|
| 2011 |
Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion in human aortic endothelial cells via AdipoR1/NF-κB/COX-2 signaling; in HAEC lacking AdipoR1 (by siRNA), gAd-mediated NF-κB activation and COX-2 overexpression were abrogated, and monocyte adhesion was greatly enhanced. The p38MAPK/VCAM-1 pathway was AdipoR1-independent. |
siRNA knockdown of AdipoR1 and COX-2, NF-κB activation assays, COX-2/PGI2 measurement, VCAM-1 expression, monocyte adhesion assay, p38MAPK phosphorylation |
American journal of physiology. Endocrinology and metabolism |
Medium |
21900123
|
| 2014 |
AdipoR1 and APPL1 mediate globular adiponectin's protective effects against angiotensin II-induced atrial hypertrophy and fibrosis; siRNA-mediated suppression of AdipoR1 or APPL1 diminished gAcrp-induced AMPK phosphorylation and its downstream suppression of NF-κB, and the effect of adiponectin required PI3K/Akt. |
siRNA knockdown of AdipoR1 and APPL1 in neonatal rat atrial cells, EMSA supershift for NF-κB p65/p50, PI3K inhibitor, AMPK phosphorylation assay, real-time PCR for hypertrophy/fibrosis markers |
PloS one |
Medium |
25099270
|
| 2022 |
AdipoR1 is directly targeted by Schisandrin A (which reduces LPS+ATP-induced AdipoR1 ubiquitination in vitro), and Schisandrin A activates AdipoR1/AMPK signaling while suppressing TXNIP/NLRP3 pathway to attenuate ferroptosis and pyroptosis in diabetic nephropathy models. |
In vitro DN model (high glucose endothelial cells), in vivo STZ/high-fat diet mouse model, AdipoR1 direct targeting assay, ubiquitination assay, AMPK and NLRP3 pathway analyses |
Oxidative medicine and cellular longevity |
Low |
35996380
|
| 2013 |
PTB and miR-221 bind the AdipoR1 3'UTR and cooperatively inhibit AdipoR1 translation; upregulation of both PTB and miR-221 in obesity models reduces AdipoR1 protein levels, providing a translational mechanism for reduced AdipoR1 in obesity. |
RNA immunoprecipitation, luciferase reporter assays, siRNA depletion and overexpression, genetic and dietary obesity mouse models |
Diabetes |
High |
24130336
|